| Code | 23375 | ||||||||||
| MA number | 59/0714/10-S | ||||||||||
| Product Form: | tbl flm 50x100 mg (obal PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | container PE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.09.2010 |
| Pediatric posology: | Yes |
| SPC: |
SPC_Immunoprin 100 mg_02.2025.pdf
|
| PIL: |
PIL_Immunoprin 100 mg_02.2025.pdf
|
| Safety feature | Yes |
| Data update: | 10.01.2018 |
